<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MyPatentBar.com &#187; MPEP 1800</title>
	<atom:link href="http://mypatentbar.com/category/mpep-1800/feed/" rel="self" type="application/rss+xml" />
	<link>http://mypatentbar.com</link>
	<description>Patent Bar Review and Study Guide</description>
	<lastBuildDate>Mon, 19 Apr 2010 18:52:57 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Patent Cooperation Treaty (MPEP 1800)</title>
		<link>http://mypatentbar.com/2007/11/28/patent-cooperation-treaty-mpep-1800/</link>
		<comments>http://mypatentbar.com/2007/11/28/patent-cooperation-treaty-mpep-1800/#comments</comments>
		<pubDate>Wed, 28 Nov 2007 18:53:05 +0000</pubDate>
		<dc:creator>patentbar</dc:creator>
				<category><![CDATA[MPEP 1800]]></category>

		<guid isPermaLink="false">http://mypatentbar.com/2007/11/28/patent-cooperation-treaty-mpep-1800/</guid>
		<description><![CDATA[Overview
The Patent Cooperation Treaty (PCT) establishes a system for filing international patent applications.  PCT is applicable to utility patents only, not design patents.
General

A PCT      application that designates the US      is a US      patent application, even if it is filed [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><strong><span style="text-decoration:underline;">Overview</span></strong></p>
<p class="MsoNormal">The Patent Cooperation Treaty (PCT) establishes a system for filing international patent applications.  PCT is applicable to utility patents only, not design patents.</p>
<p><strong><span style="text-decoration:underline;">General</span></strong></p>
<ul>
<li>A PCT      application that designates the US      is a US      patent application, even if it is filed in another receiving office.</li>
<li>The      102(b) statutory bar is measured back from the PCT filing date</li>
<li><!--[if !supportLists]-->R1.48 may not be used to correct inventorship in a national stage application where the inventors were named erroneously in the application (i.e., the national stage of PCT application).</li>
<li>Section 365 (c) is a special case.  An international application (PCT) may be treated as the parent application until 30 months from the international filing date, and an applicant may file a continuation application within that time.</li>
<li><!--[if !supportLists]-->For applications filed on or after 11/29/00, if any claim for benefit is made to a prior PCT application, the first sentence of the specification must state whether the application was published in the English language.  (This does not apply to the national stage of a PCT application.)<!--[endif]--></li>
<li class="MsoNormal">The PCT application is published.</li>
<li>A PCT application may claim      priority to an earlier filed US      application, and a US      application may claim priority to an earlier filed PCT application.</li>
</ul>
<p><strong><span style="text-decoration:underline;">International Applications Filed in US</span></strong></p>
<p class="MsoNormal"><em>Who – </em>A PCT application designating the US must include one applicant who is a resident or national of the US, and the application must be made in name of inventors.</p>
<p class="MsoNormal"><em>How to file</em> – PCT applications may not be filed via fax</p>
<p class="MsoNormal"><em>What to file</em> –</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->1)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->PCT request,</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->2)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->abstract and filing fees are typically paid upon filing but may be paid subsequently</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->3)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->the priority claim should be made when filing the application; if priority is to a prior US application, a certified copy of the priority application to the International Bureau will be submitted</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->4)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->filing implicitly carries a request for a foreign filing license</p>
<p class="MsoNormal"><em>For a filing date, you need &#8211; </em></p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->1)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->indication that at least one applicant is a resident or national</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->2)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->indication that app is an international app</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->3)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->designation of at least one contracting state</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->4)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->name of applicants</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->5)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->description in English</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->6)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->drawings</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->7)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->at least one claim</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]--> <img src='http://mypatentbar.com/wp-includes/images/smilies/icon_cool.gif' alt='8)' class='wp-smiley' /> <span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->if the app designate US, name, address, signature of EACH inventor (or attorney) and any app to which domestic priority is claimed shall be included</p>
<p class="MsoNormal" style="margin-left:0.5in;text-indent:-0.25in;"><!--[if !supportLists]-->9)<span style="font-style:normal;font-variant:normal;font-weight:normal;font-size:7pt;line-height:normal;font-family:'Times New Roman';"> </span><!--[endif]-->indication as to which international search authority</p>
<p><strong><span style="text-decoration:underline;">International Stage</span></strong></p>
<p class="MsoNormal"><em>Chapter I</em> – the following events occur or may occur:</p>
<ul>
<li class="MsoNormal">the      ISA determines whether there is unity of invention</li>
<li class="MsoNormal">the      ISA establishes a search report</li>
<li class="MsoNormal">the      applicant has one opportunity to amend the claims within 2 months after      establishment of search report</li>
<li class="MsoNormal">the      application is published at 18 months</li>
<li class="MsoNormal">applicant      may file a demand for Chapter II proceedings (19 month)</li>
<li class="MsoNormal">applicant      may enter the national stage in any designated state (30 month)</li>
<li class="MsoNormal">a      Chapter II demand may be filed via fax</li>
<li class="MsoNormal">applicant      may demand examination for all or fewer of the states originally      designated; these states become elected states</li>
</ul>
<p class="MsoNormal"><em>Chapter II</em></p>
<ul>
<li class="MsoNormal">if the      applicant files a chapter II demand by the 19 month date, the application      will be subjected to international preliminary examination before an      international preliminary examining authority (IPEA)</li>
<li class="MsoNormal">the      IPEA will usually issue a written opinion based on the search report and      other aspects of the application (optional)</li>
<li class="MsoNormal">the      applicant has the opportunity to reply to the written opinion, such reply      may include arguments and amendments to the claims</li>
<li class="MsoNormal">the      international preliminary examination report (IPER) will issue</li>
<li class="MsoNormal">the      written opinion will discuss novelty, inventive step, and industrial      applicability, as well as unity of invention and formal matters</li>
<li class="MsoNormal">the      IPER will provide a statement as to novelty, inventive step, and      industrial applicability; it is not a statement as to patentability</li>
</ul>
<p class="MsoNormal"><strong><span style="text-decoration:underline;">National Stage &#8211; 365(c)</span></strong></p>
<p class="MsoNormal">Deadline to enter national stage is 30 months from first priority date/PCT filing date.  To enter US national stage, applicant must file: 1) fee, 2) when required, a copy of the international application and English translation, 3) when required, amendments with English translations, and 4) oath/declaration of the inventor.  In practice, usually the fee and cover sheet are all that is required by the 30-month deadline.</p>
<p class="MsoNormal">A petition to revive may be filed if the application does not meet the necessary requirements by the 30-month date.</p>
<p class="MsoNormal">The application is subject to publication if the PCT application was filed on or after 11/29/00.</p>
<p class="MsoNormal">
<p class="MsoNormal"><a name="4233576303097351595"></a><strong><span style="font-size:14pt;">Chapter 1800: The Patent Cooperation Treaty</span></strong><br />
<!--[if !supportLineBreakNewLine]--><br />
<!--[endif]--></p>
<p class="MsoNormal">It is possible to file an app in the US and make it international in scope (an IA such that it can be valid in a PCT member country which includes 120 other countries), <strong>or</strong> an international app that was filed in a foreign country can be brough to the US and be able to benefit from its original international effective filing date (102(e) in action).</p>
<p>Main steps in the PCT: (more details below).</p>
<ol type="1">
<li class="MsoNormal">1. The IA must be filed in      a <em>receiving office</em> (RO) in a member country of the PCT. In the U.S.      the USPTO may act as the receiving office.</li>
<li class="MsoNormal">2. After going to the      receiving office, the app is sent to the <em>International Searching      Authority </em>(ISA). The ISA does an initial prior-art search. In the U.S.,      an app will usually be able to either get the USPTO, or the European      Patent Office to do the International search. The ISA does a search, and      also issues a preliminary &amp; non-binding opinion as to whether it      thinks the patent is actually novel, involves an (obviousness?), involves      an <em>inventive step </em>(obviousness?), and finally if the app is <em>industrially      applicable </em>(sounds like a proxy for utility.</li>
<li class="MsoNormal">3. After the prior art      search, the app goes to the <em>International Bureau</em> (IB). The IB is      the central office for the IA, and usually at the expiration of 18 months      of the priority date (original filing date of the IA) it will publish the      application. The IB is also the central point from which copies of the app      get sent to member countries (like the U.S.)
<ol type="1">
<li class="MsoNormal">Amendments to       claims: There is a <strong>2 month</strong> limit on amending claims after the ISA       (usually to get the amendments put in before the 18 month publishing       date).</li>
</ol>
</li>
<li class="MsoNormal">4. After the priority date      is given, the applicant has 30 months to select a <em>Designated Office. </em>(DO)<em> </em>This is where the app actually comes onto the national stage (35      U.S.C. 371 in the U.S.).      By meeting the requirements to come onto the national stage within 30      months of the pirority date the app can come here.</li>
<li class="MsoNormal">5. <strong>OPTIONALLY: </strong>The      applicant may desire there to be an <em>international preliminary      examination</em> of the patent app. The applicant can request this by      filling out a <em>Demand</em>, the demand has to be filed within <strong>3 months      of the ISA, or 22 months of the original priority date</strong>. The demand      goes to the <em>International Preliminary Examination Authority</em> (IPEA),      and the USPTO acts as the IPEA for international apps that are filed in      the U.S. (where the US      is the original RO). The preliminary exam allows the examiner to make      comments on:
<ol type="1">
<li class="MsoNormal">1. lack of unity of       invention;</li>
<li class="MsoNormal">2. note errors;</li>
<li class="MsoNormal">3. issue written       opinions on the novelty, &#8216;inventive step&#8217;, and &#8216;industrial applicability&#8217;       of each claim;</li>
<li class="MsoNormal">4. <strong>TIME: </strong>Even       with this optional step, the applicant <strong>still</strong> must meet the       national stage requirements within 30 months of the original priority       date (this optional step does not extend that deadline in any way).</li>
</ol>
</li>
</ol>
<p class="MsoNormal">1803: The Publication by the IB is not required if the US is the only country designated in the IA. (This means that for apps that only designate the US the app will not be published after 18 months since it is not necessary).</p>
<p>1805: Where to file an IA (35 U.S.C. 361):</p>
<ol type="1">
<li class="MsoNormal">Remember: The IA cannot be      initially filed in the US      (with the USPTO acting as the RO) unless <strong>at least one applicant</strong> is      a citizen or resident of the U.S.</li>
<li class="MsoNormal">Because of the fact that      the U.S. requires      inventors to at least sign oaths/decls on the patent (other countries do      not require this) the <strong>applicant</strong> in this case has to be an inventor      (at least 1 inventor is a U.S.      citizen/resident). (This is a case of U.S. patent law being stricter      than what the PCT requires)</li>
<li class="MsoNormal">Remember the 37 CFR 1.10      Express Mail provisions. They <strong>do </strong>apply to IAs (like the date of      mailing will be the effective received date). However, the Mailing      Certificate practice <strong>does not</strong> apply to IAs.</li>
</ol>
<p class="MsoNormal">Faxes: They cannot be used for transmitting apps, drawings, copies of the app (needed for entering the national stage). However, faxes may be used for other transmissions, the fax certificate does <strong>not</strong> apply for IA documents.</p>
<p class="MsoNormal"><strong>1810: Getting the International Filing Date:</strong><br />
37 CFR 1.431; 35 U.S.C. 363, 373; PCT 11</p>
<ol type="1">
<li class="MsoNormal">1. At least one applicant      must be a U.S. Resident to use the U.S. as an RO and get an      International Filing Date</li>
<li class="MsoNormal">2. The IA must be in      English</li>
<li class="MsoNormal">3. The IA must contain at      least the following:
<ol type="1">
<li class="MsoNormal">1. An indication       that the app is intended to be an IA</li>
<li class="MsoNormal">2. The designation       of at least one Contracting        State (member) of       the Patent Cooperation Union;</li>
<li class="MsoNormal">3. The name of the       applicant (before 20040101 this had to be all applicants, but on or after       20040101 it only needs to be 1 applicant).</li>
<li class="MsoNormal">4. A section that       contains a description; (starting on its own page; this includes       necessary drawings too)</li>
<li class="MsoNormal">5. A section with at       least 1 claim (again, separate page).</li>
</ol>
</li>
</ol>
<p class="MsoNormal">As soon as all the above elements are met, the USPTO will give an international filing date to the IA.</p>
<p><strong>1812:</strong> The IA must have a <em>request</em>, description, claims, abstract, and necessary drawings (note that this is <strong>more</strong> than is needed to just get the international filing date).</p>
<p><strong>1817.01: How states are designated on IAs occurring on or after 20040101</strong> (basically, a proper <em>request</em> means all countries are automatically designated):<br />
The IA request constitutes:</p>
<ol type="1">
<li class="MsoNormal">1. all member states of the      PCT are designated;</li>
<li class="MsoNormal">2. A request for every form      of patent protection available in each state;</li>
<li class="MsoNormal">3. Remember: For coming to      the U.S.      the actual inventors must still be indicated as (at least some) of the      applicants on the request (this is not necessary in other countries).</li>
</ol>
<p class="MsoNormal"><strong>1817.02: Indicating a Continuation or CIP in the IA: </strong>(when there is an earlier national app):</p>
<ol type="1">
<li class="MsoNormal">The request should indicate      that it is seeking benefit from a prior US or prior IA designating the US.      (check the &#8216;Supplemental&#8217; box)</li>
<li class="MsoNormal">The specific relationship to      the parent app (like is this new app an RCE, or a CIP with new matter)      should be specified, and the parent app should be clearly identified (with      app number)</li>
<li class="MsoNormal">Note: Just because the      request properly identifies the parent app, the applicant <strong>still has</strong> to have a proper ADS that claims benefit of the prior app, or      alternatively the IA must identify the prior app in the first sentence(s).      (Same as rules in normal US      apps, see 37 CFR 1.178(a)(2)).</li>
</ol>
<p class="MsoNormal"><strong>1819: Getting a Refund when there was an earlier ISA:</strong> Some ISA&#8217;s refund part of the $$ if there already was a search done on the same subject matter. So if there already was a search on a normal US app (35 U.S.C. 111) then there could be a discount for an IA on the same material.</p>
<p><strong>1820: Sig of Applicant:</strong><br />
Before 20040101: All applicants had to sign, but if one was unavailable or refused the other applicants could file a statement explaining why the other applicant did not sign.</p>
<p>After 20040101: Just one applicant needs to sign.</p>
<p>1823-1825: Description; Claims; Drawings:</p>
<ol type="1">
<li class="MsoNormal">1. The description should      clearly describe the invention such that the OSP could practice it (big      surprise); The PCT has 6 sections it wants the description divided into:
<ol type="1">
<li class="MsoNormal">1. Technical Field</li>
<li class="MsoNormal">2. Background Art</li>
<li class="MsoNormal">3. Disclosure of       Invention.</li>
<li class="MsoNormal">4. Brief Description       of Drawings</li>
<li class="MsoNormal">5. Best mode for       Carrying out Invention (or Mode(s) for carrying out invention)</li>
<li class="MsoNormal">6. Industrial       applicability (utility)</li>
<li class="MsoNormal">7. &#8211;&gt; Where       applicable: Sequence listings (like for DNA sequences)</li>
</ol>
</li>
<li class="MsoNormal">Claims: They define the      matter for which protection is sought (yay), clear &amp; concise, fully      supported in disclosure; PCT likes 2 chunks:
<ol type="1">
<li class="MsoNormal">1. A statement of       the prior art</li>
<li class="MsoNormal">2. The       &#8216;characterizing features&#8217; for which protection is sought in this       invention</li>
</ol>
</li>
<li class="MsoNormal">2. Drawings: If necessary      the IA should contain drawings. While there is no express provision for      photos, they are allowed if they are necessary for understanding the      invention. The <strong>only</strong> way to amend drawings is if the applicant makes      the (optional) demand for an IPE (International Preliminary Examination).</li>
</ol>
<p class="MsoNormal">And onto 51:</p>
<p>1826: <strong>The Abstract:<br />
</strong>This should contain a brief (50-150 word) synopsis of the inventi0n, its field, technical problems solved, gist of how the invention solves the problem, principle uses of the invention, main features, &amp; chemical formulas (if any).</p>
<p>1827: Fees: There are filing, transmittal, search fees all payable on the filing date of the IA.</p>
<p><strong>1828: Being able to claim Priority over an Earlier App:</strong></p>
<ol type="1">
<li class="MsoNormal">1. To claim priority over an      earlier national or IA, the claim for priority must be in the IA request,      and it must contain: the country where the app was filed, date of filing,      and application number (all of these are taken as what was true as of the      filing date of the later IA).</li>
<li class="MsoNormal">2. In case the applicant      forgets to or puts an invalid priority claim down, the applicant can      correct the priority claim either: (Think about it this way, the claim of      priority should happen within <strong>12 months</strong> of the filing of the later      IA, these rules maintain the 12 month time between filing dates, but tack      on 4 months for corrections):
<ol type="1">
<li class="MsoNormal">1. Within 16 months       of the filing date of the original app the applicant is claiming priority       over; or</li>
<li class="MsoNormal">2. Within 4 months       of filing the later IA.</li>
</ol>
</li>
<li class="MsoNormal">3. The applicant has to      have a <em>certified copy</em> of the original app that is being prioritized      (in the U.S.      it might need an English translation if not in English). This needs to be      in either within 16 months of the priority date of the earlier app, or      before examination begins.</li>
</ol>
<p class="MsoNormal">1832: Licenses for Foreign Filing:</p>
<ol type="1">
<li class="MsoNormal">Memory Lane: Remember, that      a normal US      app has to either 1. have a <em>foreign license</em> to be concurrently      filed in a foreign country; <strong>or</strong> the applicant has to wait 6 months      to file in the foreign country (assuming no national security orders are      put on the app).</li>
<li class="MsoNormal">If the new IA is not      disclosing any new matter that was not already in an earlier US      app that already had the foreign license, or was already filed &gt; 6      months prior, it is OK to push internationally.</li>
</ol>
<p class="MsoNormal">1834: Correspondance: (Mail time again):</p>
<ol type="1">
<li class="MsoNormal">1. When the Office gets a      mailing that does not properly ID the app to which the papers relate, it      will contact the applicant/agent to get this corrected.</li>
<li class="MsoNormal">2. If there is just 1      applicant with no agent(s) the mailings go to the applicant at designated      addr; otherwise they first go to agents.</li>
<li class="MsoNormal">3. Remember: the 37 CFR 1.10      <em>Express Mail</em> provisions <strong>do </strong>apply, <strong>BUT</strong> the 37 CFR 1.8      &#8220;certificate&#8221; practice <strong>does not apply to an IA.</strong></li>
</ol>
<p class="MsoNormal">1834.01: Faxing Stuff: It may be allowed but not for:</p>
<ol type="1">
<li class="MsoNormal">1. Anything that needs to be      &#8216;certified&#8217; (this means: the app itself, certified copies of other apps,      drawings, other docs required by statute to be certified).</li>
<li class="MsoNormal">2. While there is no &#8216;fax      certificate&#8217;, the normal rules (a fax is considered transmitted on the      date of the <strong>final</strong> page being received at the USPTO, time extends      over weekends to next business day).</li>
</ol>
<p class="MsoNormal"><strong>1836: It is possible to fix <em>obvious</em> errors:</strong></p>
<ol type="1">
<li class="MsoNormal">Obvious does <strong>not</strong> mean if whole pages are missing from the app (even if it is obvious that      the pages are missing, and they were only omitted due to clerical error)</li>
<li class="MsoNormal">It <strong>does</strong> mean,      spelling, linguistic, grammatical errors, as long as no underlying meaning      of the app is changed.</li>
</ol>
<p class="MsoNormal">1840: The ISA:</p>
<ol type="1">
<li class="MsoNormal">Remember, the ISA does 3      main things: 1. It makes an international search for prior art; 2. It      makes a report on what it found; 3. For apps on or after 20040101, it      makes an opinion about whether or not prior art defeats the claims.</li>
<li class="MsoNormal">Using the European Patent      Office as the ISA: This is generally allowed when using the USPTO as the      RO, but there are 3 big exceptions: Biotech, Business Method, &amp;      Telecomms patents should not go to the European office for ISA, they      should stay in the US.</li>
</ol>
<p class="MsoNormal"><strong>1842: The &#8216;flow&#8217; of the IA process: DEADLINES!!</strong></p>
<ol type="1">
<li class="MsoNormal">1. Remember, all time      periods are measured from the <em>priority date</em> of the IA. This means      if the applicant is claiming priority over an earlier national app or IA      that earlier date is what everything gets measured against. If there is no      claim of priority in the IA, the <em>priority date</em> is just the date of      filing the IA itself.</li>
<li class="MsoNormal">2. International Filing      Dates: Remember, in order to actually get the priority over an earlier      app, the IA that claims priority over that app needs to be filed within <strong>12      months</strong> of the earlier app&#8217;s filing date.</li>
<li class="MsoNormal">Time for establishing the      International Search Report (from the ISA): The time limit is either 3      months from the time the ISA receives its copy of the app, or 9 months      from the priority date, whichever occurs later.</li>
<li class="MsoNormal">Publication: The app will      get published promptly after <strong>18 months</strong> from the priority date of      the app.</li>
<li class="MsoNormal">Deadline for Filing a <em>Demand</em> in order to get an (optional) Preliminary Examination (from the IPEA): The      demand must be filed before the latter of: 1. <strong>3 months</strong> from the      date of transmittal to the ISA; or 2. <strong>22 months</strong> from the original      priority date. Remember, the 30 months from the priority date deadline <strong>still</strong> applies in moving the app onto the national stage. Therefore, it might      mean that as a practical matter the app has to go to IPEA sooner than the      above deadlines.</li>
<li class="MsoNormal">Deadline for filing a copy,      translation, &amp; fees for moving the app onto the National Stage: a. 30      months from the priority date under chapter I; b. The PCT sets the      deadline at 30 months, but individual nations could set the limit as      longer than 30 months if they want (30 months is a common minimum).</li>
</ol>
<p class="MsoNormal"><strong>1850: Unity of Invention Before the ISA: </strong>(like a restriction requirement when there are multiple independent inventions in one app):</p>
<ol type="1">
<li class="MsoNormal">1. There must be a &#8216;unity&#8217;      of invention (1 invention per app, or if there are multiple inventions they      must be linked to form a &#8217;single general inventive concept&#8217;).</li>
<li class="MsoNormal">2. As long as the      independent claims avoid prior art and also satisfies unity of invention      (by having 1 invention or by having a single inventive concept via      &#8217;special technical features&#8217; that are shared by the inventions).</li>
<li class="MsoNormal">3. If there is little or no      extra effort involved in searching for multiple inventions, the ISA will <strong>not</strong> charge an extra fee.</li>
<li class="MsoNormal">4. However, if there is      substantial extra effort, the ISA will still perform searches if the      applicant pays extra fees. The ISA will invite the applicant to pay the      extra search fees on additional inventions. Remember: The ISA is not the      final arbiter of unity or patentability, it is just doing prior art      searches and giving a non-binding preliminary report. If the applicant      does not pay the extra fees, parts of the IA will not be searched.</li>
<li class="MsoNormal">5. Protesting: When the      applicant thinks the ISA is wrong, the applicant can file a statement of      protest over lack of unity, or of extra fees, and to the extent this convinces      the ISA, the fees may be waived.</li>
</ol>
<p class="MsoNormal"><strong>1853: Amending Claims under PCT 19:</strong></p>
<ol type="1">
<li class="MsoNormal">There is <strong>ONE</strong> opportunity to amend the <strong>claims</strong> (and only the claims) after the ISA      issues its report. The applicant has <strong>2 months</strong> from the time the      search report is mailed to amend claims in the IA. If received in time,      the IB&#8217;s publication will contain the amended claims.</li>
</ol>
<p class="MsoNormal"><strong>1857.01: Review of 102(e) and 20001129 issues with IAs:</strong></p>
<ol type="1">
<li class="MsoNormal">On or after 20001129:
<ol type="1">
<li class="MsoNormal">If the IA designates       the US</li>
<li class="MsoNormal">If it was published       in English.</li>
<li class="MsoNormal">Then: The IA is       available as prior art under 102(e) and also, the applicant will be able       to get the date of the IA as the 102(e) date when moving the app onto the       national stage.</li>
<li class="MsoNormal">If <strong>not</strong> designating US or in English: Then the app is not available under 102(e),       however, the published app <strong>is</strong> available under 102(a) or 102(b) so       be careful!</li>
</ol>
</li>
<li class="MsoNormal">Before 20001129:
<ol type="1">
<li class="MsoNormal">There is no ability       to get the earlier filing date of the IA for 102(e) purposes here.</li>
</ol>
</li>
</ol>
<p class="MsoNormal"><strong>1859: Withdrawing an IA or claims:</strong></p>
<ol type="1">
<li class="MsoNormal">As long as withdrawal is      done within 30 months of the priority date (deadline for moving onto the      national stage) the applicant may withdraw: the whole app; a designation      of a country; or a priority claim.</li>
<li class="MsoNormal">Appointed agents can      withdraw, or the applicant can do it.</li>
</ol>
<p class="MsoNormal"><strong>1860: The IPEA process:</strong></p>
<ul type="disc">
<li class="MsoNormal">Step 1: The IPE will read      the app, and the opinion of the ISA. If the ISA used is either the USPTO      or European Patent Office, the ISA&#8217;s opinion will be considered a valid <em>initial      opinion,</em> and the USPTO will generally not write up another <em>initial      opinion</em> in those cases (only where there is no other initial opinion).</li>
<li class="MsoNormal">Step 2: If the applicant is      protesting a negative opinion present in the ISA&#8217;s opinion, then the      applicant can protest this finding and get a <em>further written opinion</em> if the USPTO thinks the protest is persuasive.
<ul type="circle">
<li class="MsoNormal">The written opinion       has to state grounds for each of its conclusions (just like in any       finding on the merits for the USPTO)</li>
<li class="MsoNormal">The applicant has       the opportunity to file a response with amendments to the app, usually       there is a <strong>2 month</strong> time limit from the time of the opinion to get       in the reply.</li>
</ul>
</li>
</ul>
<p class="MsoNormal"><strong>1864: The Demand for IPE, and the ability to amend:</strong><br />
The applicant has the option to file a demand for IPE, and if that occurs the applicant may also amend the app. This amendment will allow the applicant to address problems with novelty/obviousness/or industrial applicability to get a positive initial report (which is important in some offices for getting a patent).<br />
Other points:</p>
<ul type="disc">
<li class="MsoNormal">As of 20040101, filing a      demand means the applicant is electing all nations that are members of the      PCT.</li>
<li class="MsoNormal">The demand should be sent      via mail straight to the IPEA (not to the IB).</li>
<li class="MsoNormal">Agents (like attys of      record or patent agents) that are allowed to practice in front of the      home-office are also allowed to practice in front of that office in its      role as IPEA (so if I&#8217;m registered for the USPTO, I can represent      applicants on an IPEA too).</li>
</ul>
<p class="MsoNormal"><strong><span style="font-size:13.5pt;"><a href="http://chuckphu.blogspot.com/2007/07/52-more-on-ipea-procedure-1870-1881.html"><span style="text-decoration:none;color:#000000;">More on IPEA procedure (1870-1881)</span></a> </span></strong></p>
<p class="MsoNormal"><strong>The IPE Exam:</strong></p>
<ol type="1">
<li class="MsoNormal">Unity Issues: The IPE only      concerns itself with inventions that were previously searched for by the      ISA. This means that if the ISA found there to be a lack of Unity (or      multiple inventions that would raise a restriction requirement in a normal      app) then only the inventions that the ISA actually searched will be      considered by the IPEA.
<ol type="1">
<li class="MsoNormal">Remember: The ISA may       <em>invite</em> the applicant to pay more fees for additional searches, if       the applicant does so then the multiple inventions will still be in the       IPE since they were searched.</li>
<li class="MsoNormal">The exact same       process will apply before the IPEA if there is no unity, the applicant       will have the choice to either restrict claims to one invention, or to       pay extra fees for additional inventions (1875.02)</li>
</ol>
</li>
<li class="MsoNormal">Further reports done by the      IPEA:
<ol type="1">
<li class="MsoNormal">Remember: On or After       20040101 all ISA searches come with an opinion of their own. Normally,       the IPE will <strong>not</strong> have a second opinion (the first ISA opinion is       considered by the IPEA).</li>
<li class="MsoNormal">However: If the       applicant files a <em>response</em> to the ISA report that persuasively argues       against negative findings (like: lack of novelty, obviousness, lack of       applicability to industry) then the IPEA will draft a second report       reflecting its findings based on the new arguments</li>
</ol>
</li>
</ol>
<p class="MsoNormal">1878: How IPEA Considers novelty/non-obviousness/industry applicability:</p>
<ol type="1">
<li class="MsoNormal">1. Novelty: The relevant      prior art date is either the IA filing date, or if priority is properly      claimed on a prior app, the priority date (remember, that cannot be &gt;      12 months before the IA filing date).</li>
<li class="MsoNormal">2. Inventive Step      (obviousness): If the OSP would not have found the invention obvious as of      the relevant priority/IA date then the invention is seen as non-obvious.</li>
<li class="MsoNormal">3. Industrial Applicability      (utility): If the invention can be made or used in any kind of industry it      is considered applicable.</li>
</ol>
<p class="MsoNormal">1878.02: Amending &amp; Replying to an IPE opinion:</p>
<ol type="1">
<li class="MsoNormal">The amendments are all due      within the deadline set forth after the examination report is made. No      extensions are allowed.</li>
<li class="MsoNormal">How do make amendments (<strong>different      than for normal apps</strong>): Instead of overstrikes/underlines, the      amendments should come on separate replacement sheets that have      explanations as to how the replacement sheets differ from the original.</li>
<li class="MsoNormal">During the time period when      reply is allowed, the applicant may request a phone or in-person      interview. All the interviews will become part of the official record.</li>
</ol>
<p class="MsoNormal">1879: Prepping the IPEA&#8217;s report (time limits):</p>
<ul type="disc">
<li class="MsoNormal"><strong>REMEMBER: NO MATTER WHAT      THE NATIONAL STAGE FEES MUST BE PAID WITHIN 30 MONTHS OF THE PRIORITY DATE      OF THE IA! NO EXTENSIONS, NO EXCUSES!. </strong>(this is the final step,      getting onto the national stage, otherwise the IA is not that useful)</li>
<li class="MsoNormal">The report&#8217;s deadline is 1      of:
<ul type="circle">
<li class="MsoNormal">28 months from the       priority date (2 months left over to enter national stage); or</li>
<li class="MsoNormal">6 months from the time       that the IPEA begins; or</li>
<li class="MsoNormal">6 months from the       receipt of the IPEA of the translation of the app or priority app.</li>
</ul>
</li>
<li class="MsoNormal">Remember: The IPEA has a time      limit of beginning 22 months after the priority date, so 22 months to      start + 6 months to conduct the IPE == 28 months total time.</li>
</ul>
<p class="MsoNormal"><strong><span style="font-size:13.5pt;"><a href="http://chuckphu.blogspot.com/2007/07/53-end-of-pcts-getting-onto-national.html"><span style="text-decoration:none;color:#000000;">The End of PCT&#8217;s: Getting onto the National Stage</span></a> </span></strong></p>
<p class="MsoNormal"><strong>What is a National Stage App?</strong><br />
Just a normal 35 U.S.C. 111(a) (NPA) or 111(b) (PA &#8211;&gt; technically possible but rare) app that is filed after the applicant has met the conditions set forth in 35 U.S.C. 371 (37 CFR 1.9).</p>
<p><strong>What is the whole PCT process really buying the applicant? </strong></p>
<ol type="1">
<li class="MsoNormal">1. Time: remember, the PCT      gives 30 months from the priority date for getting the <strong>filing fee</strong> submitted on the national stage. Under a U.S. app, filings in foreign      countries would normally: (a) only get foreign priority not full benefits      given by the PCT; (b) only have a 12 month window from the earliest      foreign filing date.</li>
<li class="MsoNormal">2. Knowledge: Remember, the      ISA and possibly IPE give you good information on the prior art and on the      patentability of the invention. This can be helpful in deciding whether to      continue, or in how to amend the app.</li>
<li class="MsoNormal">Example 1: Japanese      applicant files normal app in Japan. 12 months later (may      time for priority in PCT) he files PCT app in Japanese RO. Now, the      Japanese applicant can enter the U.S. stage within 30 months of      the priority date (and gets 102(e) benefits if the patent is published in      English)&#8230; more time! Alternatively, the Japanese applicant could also go      ahead and file a normal 111(a) app in the U.S. (in English) that claims      the benefit of the PCT app at any time during the 30 month pendency of the      PCT app.</li>
<li class="MsoNormal">Example 2: Say the applicant      is American, and files a normal app in the USPTO. 12 months later, he      files an IA using the USPTO as RO. The U.S.      applicant can now either enter the Japanese stage by making sure the fee      is paid within 30 months of the priority date, or just file a normal      Japanese app in Japan      that claims prioirity over the IA during the pendency of the IA.      (Reciprocal rules!)</li>
</ol>
<p class="MsoNormal"><strong>Remember: To enter the National Stage, the basic national stage fee MUST be paid by 30 months after the priority date! </strong>(37 CFR 1.492) It can be paid in the usual ways (charge account with USPTO, CC, check, etc)</p>
<ul type="disc">
<li class="MsoNormal">The applicant can come into      the national stage earlier than 30 months out too (35 U.S.C. 371(f)) as      long as all the requirements are met (35 U.S.C. 371(c)):</li>
<li class="MsoNormal">The requirements to actually      get on the national stage are:
<ul type="circle">
<li class="MsoNormal">1. The National Fee       (the $, and the one thing that <strong>has </strong>to be in before the 30 month       priority deadline)</li>
<li class="MsoNormal">2. A copy of the app       (this includes amendments that may have been made) It is provided by the       IB; and if needed translations to English are also required. (also <strong>has</strong> to be in by 30 months)</li>
<li class="MsoNormal">3. If any amendments       were made to <strong>claims</strong> under PCT 19 (that 2 months after the ISA report)       then those amendments should be forwarded too.</li>
<li class="MsoNormal">4. Oaths/decls of the       inventor(s) or other parties who would be valid under 35 U.S.C. 111, and       115.</li>
<li class="MsoNormal">5. If the ISA/IPEs       are not in English, translations of those as well.</li>
<li class="MsoNormal">6. The normal       filing/search/exam/app size fees that would be paid for a normal app.</li>
</ul>
</li>
<li class="MsoNormal">If the National Fee &amp;      basic app are in by the 30 month (non-extendable) deadline, but the      oath/decl, translation, other fees are <strong>not</strong> on time, they can be put      in later under the following rules:
<ul type="circle">
<li class="MsoNormal"><strong>2 month </strong>basic       deadline</li>
<li class="MsoNormal">Extendable by 5       months (37 CFR 1.136(a))</li>
</ul>
</li>
<li class="MsoNormal">IF: the papers that are      filed are on time but deficient then abandonment results, if it was      unintentional then the 37 CFR 1.137 revival process might work to bring      the app back.</li>
</ul>
<p class="MsoNormal"><strong>When is the effective filing date for an IA that enters the National Stage?</strong><br />
Under 35 U.S.C. 363 and PCT 11: It is the proper date of the IA itself. If the IA is seeking earlier priority, that priority must be valid to get the earlier priority date. Examples:</p>
<ul type="disc">
<li class="MsoNormal">Foreign Priority: The U.S.      app has to claim foreign priority over the same app claimed in the IA to      get the priority. If priority is <strong>not</strong> claimed at the International      Stage, it is <strong>not</strong> available at the National Stage. Remember the      earlier rules on claiming a prior filing: The applicant needs to have a      certified copy to the IB by 16 months of the priority date (or 4 months      after the filing date).
<ul type="circle">
<li class="MsoNormal">If the IB sent a       certified copy of the earlier app to the USPTO the applicant is OK,       otherwise the applicant will have to provide a certified copy to the       USPTO.</li>
</ul>
</li>
<li class="MsoNormal">A prior U.S. PA: The      National Stage app must comply with 37 CFR 1.78(a)(4):
<ul type="circle">
<li class="MsoNormal">Review: At least 1       inventor in common &amp; at least one claim in the new app must pertain       to the named inventor&#8217;s prior invention!</li>
<li class="MsoNormal">Time: Remember, a PA       is only good for 12 months, this does not change that fact of pendency,       the National Stage can only benefit if filed within 12 months.</li>
</ul>
</li>
<li class="MsoNormal">A prior US NPA: The National      Stage App must comply with 37 CFR 1.78(a)(3):
<ul type="circle">
<li class="MsoNormal">Review: At least 1       inventor in common &amp; at least one claim in the new app must pertain       to the named inventor&#8217;s prior invention!</li>
<li class="MsoNormal">Remember: the earlier       app must be copending!</li>
</ul>
</li>
</ul>
<p class="MsoNormal"><strong>What are the big differences between an IA and a normal national App:</strong></p>
<ul type="disc">
<li class="MsoNormal">Remember: While the      applicant may choose to file a 35 U.S.C. 111(a) app that claims benefit on      the IA instead of moving onto the national stage, the rules on unity are      different between the 2 apps.</li>
<li class="MsoNormal">The Oath for international      apps (under 37 CFR 1.497) must identify and have <strong>all</strong> inventors sign      (if they are available to so). This puts it in accord with 37 CFR 1.63      oath/decl which are the normal oaths executed on US apps.
<ul type="circle">
<li class="MsoNormal">However:       non-inventors signing onto the national-stage Oath/decl may do so as long       as they state their relationship with the inventors (normally under 1.63 non-inventors       like assignees do not sign).</li>
</ul>
</li>
<li class="MsoNormal">FILING DATE DIFFERENCES for      102(e):
<ul type="circle">
<li class="MsoNormal">To get a 35 U.S.C.       111(a) the (basic) filing date is: 1. description; 2. at least 1 claim;       3. necessary drawings. (see claiming priority/benefit below)</li>
<li class="MsoNormal">For a 371 filing       date: It is instead the filing date of the IA! (IA had to be published in       English!)</li>
</ul>
</li>
<li class="MsoNormal">Foreign Priority      REquirements (35 U.S.C. 119(a)-(d)):
<ul type="circle">
<li class="MsoNormal">For 35 U.S.C. 111(a):       There needs to be a claim of priority (in the Oath/decl!), and also a       certified copy of the foreign app (plus translations)</li>
<li class="MsoNormal">35 U.S.C. 371: Claim       by applicant still needed, only now there only needs to be a copy of the       foreign app that was <strong>previously</strong> received by WIPO. (Remember, to       get foreign priority the original IA must have claimed foreign priority       as well)</li>
</ul>
</li>
<li class="MsoNormal">Unity of Invention:
<ul type="circle">
<li class="MsoNormal">35 U.S.C. 111(a):       Remember: NORMAL RESTRICTION PRACTICE       (37 CFR 1.141-146)</li>
<li class="MsoNormal">35 U.S.C. 371: Unity       Practice (37 CFR 1.475)</li>
</ul>
</li>
<li class="MsoNormal">Different Filing Fees:
<ul type="circle">
<li class="MsoNormal">35 U.S.C. 111(a): 37       CFR 1.16</li>
<li class="MsoNormal">35 U.S.C. 371: 37 CFR       1.492</li>
</ul>
</li>
<li class="MsoNormal">A reference to the copending      IA in the Declaration (first sentences) or ADS:
<ul type="circle">
<li class="MsoNormal">35 U.S.C. 111(a):       Attach the IA, give U.S.       application numbers for copending U.S. apps, etc.</li>
<li class="MsoNormal">35 U.S.C. 371: Same       as 111(a)</li>
</ul>
</li>
<li class="MsoNormal">Copendency with the IA:
<ul type="circle">
<li class="MsoNormal">35 U.S.C. 111(a): If       filed during pendency of the IA, the applicant must show proof of the IA       and that he is the owner of the IA, etc.</li>
<li class="MsoNormal">35 U.S.C. 371: Moot       point, all the requirements for getting onto the national stage meet the       proof requirements.</li>
</ul>
</li>
</ul>
<p class="MsoNormal"><strong>What is the &#8216;Unity Practice&#8217; regulation (37 CFR 1.475):</strong><br />
Remember: An IA brought onto the National STage via 35 U.S.C. 371 uses a <strong>different</strong> form of unity than a normal 35 U.S.C. 111(a) app. In fact, even if a 35 U.S.C. 111(a) app is filed that claims the benefit of an IA (like during the PCT process if the applicant files in the U.S. normally) the 35 U.S.C. 111(a) app <strong>always</strong> uses normal restriction practice:</p>
<p>37 CFR 1.475:<br />
Remember, unity means there is either only one invention, or that multiple inventions are part of the general inventive concept (meaning they are linked together via &#8217;special technical features&#8217;).</p>
<p>If the invention meets 1 (<strong>and only one</strong>) of the following criteria it is considered in unity:</p>
<ol type="1">
<li class="MsoNormal">product + process patent      where the process is specially adapted to make the product (although the      product might be made in other ways too); or</li>
<li class="MsoNormal">product + use patent where a      product and the method for using the product are described; or</li>
<li class="MsoNormal">product + process of use +      process of manufacture for describing the product/how to make/how to use;      or</li>
<li class="MsoNormal">process + apparatus that is      specifically designed to carry out the process; or</li>
<li class="MsoNormal">a product + process app      where there is also a specific apparatus used to carry out the claimed      process.</li>
</ol>
<p class="MsoNormal">If there are issues with unity, the examiner can require an election of an invention and make a restriction. Remember, an IA moved onto the national stage can have divisionals and other continuations just like a normal app.</p>
]]></content:encoded>
			<wfw:commentRss>http://mypatentbar.com/2007/11/28/patent-cooperation-treaty-mpep-1800/feed/</wfw:commentRss>
		<slash:comments>12</slash:comments>
		</item>
	</channel>
</rss>
